RE:RE:RE:RE:RE:RE:RE:RE:RE:New corporate presentationI can't find anything explaining the sudden increase interest but it is not what JFM suggested as many of their previous PRs do mention business updates.
I am not even sure the trading was solely from the retail but they added 50 or more watchers on Stocktwits which are usually retail. I do agree the current undervaluation is due lack of belief in the prospect of THTX's commercial and R&D operations my issue with their marketing approach is targeting only institutional investors which is so unnecessary and frustrating that me it is and been a missed opportunity when the retail investors are still a big part of the investment community. I started a business last year in a competitive space, we spend heavily on the marketing from the beginning, google, social media platforms, pulling out construction permits
palinc2000 wrote: How can you tell the trading today in the US was from retail?
I really thought that thru IR and other sources some investors have finally realized that the market cap did not even represent the value of existing legacy drug sales So the current SP does not take into account any increase in legacy drugs sales nor any potential positive development in the pipeline.
No downside and only upsides is a great investment thesis if you concur with that opinion
Why today?
I think it has been in the works for the past few weeks